PF-Atlas › Clinical Trials › NCT01744067
The Effects of Omega-3 Fatty Acids in Renal Transplantation
Omega-3 fatty acids · Phase 4
Registry ID
NCT01744067
Phase
Phase 4
Status
Completed
Drug / intervention
Omega-3 fatty acids
Sponsor
Oslo University Hospital
Start
2013-11
Enrollment
132
Locations
2
About this trial
Omega-3 fatty acids are provided through dietary intake of fish and seafood. Several dietary supplements containing omega-3 fatty acids are also commercially available. Some studies have described beneficial effects from omega-3 fatty acids, among them are anti-inflammatory, anti-thrombotic, anti-atherosclerotic, anti-arrhythmic, anti-hypertensive and lipid-modulating effects. Other studies have not confirmed these findings. This study will investigate the effects of omega-3 fatty acids on renal function and cardiovascular risk markers in renal transplant recipients.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT01744067 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.